Biofrontera AG has announced an update regarding its subsidiary, Biofrontera Inc., based in the United States. The German Biofrontera Group has deferred the receivables from Biofrontera Inc. amounting to EUR 1.8 million until June 22, 2025. This decision follows ongoing negotiations aimed at revising the existing license and supply agreement between the two entities. If both parties agree on a term sheet by the stipulated date, the payment period will be further extended until June 27. This extension reflects the commitment of both companies to reach a mutually beneficial agreement.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biofrontera AG published the original content used to generate this news brief on June 18, 2025, and is solely responsible for the information contained therein.